HomeNAV • CVE
Navco Pharmaceuticals Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.10K | -97.31% |
Net income | -10.44K | 96.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 8.44K | 103.34% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.38K | -98.27% |
Total assets | 56.27K | -90.73% |
Total liabilities | 923.46K | 16.69% |
Total equity | -867.20K | — |
Shares outstanding | 57.07M | — |
Price to book | -0.50 | — |
Return on assets | -27.01% | — |
Return on capital | 2.27% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.44K | 96.16% |
Cash from operations | -977.00 | 99.34% |
Cash from investing | — | — |
Cash from financing | -4.99K | 19.17% |
Net change in cash | -5.97K | 96.15% |
Free cash flow | -29.08K | 95.05% |
Previous close
$0.010
Year range
$0.0050 - $0.12
Market cap
570.70K CAD
Avg Volume
12.40K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
About
Headquarters
Website
